Impact of Obesity on Ventricular Assist Device Outcomes.

ABSTRACT:

Background

Obesity remains a relative contraindication for heart transplantation, and hence, obese patients with advanced heart failure receive ventricular assist devices (VADs) either as a destination or "bridge to weight loss" strategy. However, impact of obesity on clinical outcomes after VAD implantation is largely unknown. We sought to determine the clinical outcomes of obese patients with body mass index (BMI) ≥ 35 kg/m²) following contemporary VAD implantation.

Methods

The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry was queried for patients who underwent VAD implantation. Patients were categorized into BMI groups based on World Health Organization classification.

Results

Of 17,095 patients, 2620 (15%) had a

SUBMITTER: Jaiswal A 

PROVIDER: S-EPMC7141964 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature